2026 NPPES data Neurology Physician NPI 1154375798 M.D.
Verify on CMS →

LYDIA ESTANISLAO, M.D.

Neurology Physician in LAS VEGAS, Nevada. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
578
Medicare Part D claims · 118 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$3.2K
127 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LYDIA ESTANISLAO, M.D. filed 578 Medicare Part D claims in 2023 as a Neurology Physician in LAS VEGAS, Nevada, prescribing 85% generic.

578
Part D claims, 2023
85%
generic prescribing
$3.2K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LYDIA ESTANISLAO, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

578 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

LYDIA ESTANISLAO, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LYDIA ESTANISLAO, M.D.?

Quality data not reported

NPI registry status

Active

Issued 05/19/2006

NPI 1154375798

Primary specialty

Neurology Physician

Mid-sized

19,866 US NPIs in this specialty

Medicare Part D claims

578 56% vs specialty avg

2023 prescription claims

Specialty avg: 1,309

Specialty distribution in Nevada

How Neurology Physician compares to other specialties among Nevada providers

Nevada providers

Neurology Physician share within Nevada

1. Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neurology Physician share within Nevada

Specialty board-certification context

Estimated specialty board-certified rate — Neurology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neurology Physician ABMS/AOA estimate

Est. board-certified rate (Neurology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neurology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LYDIA ESTANISLAO, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 4206 W CHARLESTON BLVD, LAS VEGAS, NV, 89102, with a listed phone of (702) 331-6709. NPI 1154375798 was issued on 05/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ESTANISLAO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 578 prescription claims written by this provider, covering 118 Medicare beneficiaries and totaling roughly $462K in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 6.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4206 W CHARLESTON BLVD
LAS VEGAS, NV 89102

Provider Details

NPI 1154375798
Specialty Neurology Physician
Credentials M.D.
Gender Female
NPI Issued 05/19/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LYDIA ESTANISLAO, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$3.2K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

LYDIA ESTANISLAO, M.D. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 578 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

578
Total Claims
$462K
Total Drug Cost
118
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,104
Total Day Supply
32,561
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$433K
Generic Drug Cost
$29K
Opioid Claims
36 (6.2% rate)

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.71
Gender Split
62% female / 38% male
Age Distribution
<65: 20, 65-74: 39, 75-84: 40, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LYDIA ESTANISLAO, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gabapentin
44
Memantine Hcl
40
Primidone
37
Donepezil Hcl
31
Alprazolam
22
Oxycodone Hcl
22
Topiramate
20
Sumatriptan Succinate
15
Diazepam
14
Carbidopa-Levodopa
Carbidopa/Levodopa
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How LYDIA ESTANISLAO, M.D. fits within the Neurology Physician landscape nationally.

19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider

LYDIA ESTANISLAO, M.D.'s 578 claims are below the specialty average of 1,309.

Nearby Neurology Physician Providers in Nevada

Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as ESTANISLAO.

Compare Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LYDIA ESTANISLAO, M.D.'s specialty?
LYDIA ESTANISLAO, M.D. specializes in Neurology Physician and practices in LAS VEGAS, Nevada. Credentials: M.D..
How much does LYDIA ESTANISLAO, M.D. prescribe under Medicare Part D?
In 2023, LYDIA ESTANISLAO, M.D. wrote 578 Medicare Part D claims totaling $462K in drug costs for 118 beneficiaries.
Where is LYDIA ESTANISLAO, M.D. located?
LYDIA ESTANISLAO, M.D. is located at 4206 W CHARLESTON BLVD, LAS VEGAS, NV, 89102. Phone: (702) 331-6709.
What is LYDIA ESTANISLAO, M.D.'s NPI number?
LYDIA ESTANISLAO, M.D.'s National Provider Identifier (NPI) is 1154375798, issued on 05/19/2006.
Does LYDIA ESTANISLAO, M.D. prescribe more brand-name or generic drugs?
LYDIA ESTANISLAO, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $433K in brand drug costs.
Does LYDIA ESTANISLAO, M.D. prescribe opioids?
Yes, LYDIA ESTANISLAO, M.D. had 36 opioid claims in 2023 with an opioid prescribing rate of 6.2%.
How many Neurology Physician providers are there in the US?
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does LYDIA ESTANISLAO, M.D. prescribe most often?
Based on 2023 Medicare Part D data, LYDIA ESTANISLAO, M.D.'s most frequently prescribed drugs include Gabapentin, Memantine Hcl, Primidone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LYDIA ESTANISLAO, M.D. accept Medicare?
LYDIA ESTANISLAO, M.D. appears in CMS Medicare data with 578 Part D claims and 118 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LYDIA ESTANISLAO, M.D.'s credentials?
LYDIA ESTANISLAO, M.D.'s NPI is 1154375798 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology